E
Power Law company profile
Evotec
Biotech & Life Sciences · Hamburg, Germany · Founded 1993 · IPO 2012 Unicorn
Valuation
$1.02B
Market cap · Apr/2026
Revenue
$867M
Latest reported FY
Global footprint
Where Evotec has talent and traffic
AI talent share
2.0%
of workforce is AI talent
(97 of 4,847 staff)
(97 of 4,847 staff)
Core AI330.68%
Other AI641.32%
Non-AI workforce4,75098%
Web traffic by country
80K
monthly visits
across markets
across markets
🇺🇸 United States19.9%
🇩🇪 Germany12.3%
🇬🇧 United Kingdom7.6%
🇫🇷 France6.5%
🇮🇹 Italy5.6%
Patent intelligence
$42M patent portfolio · 56 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$42M
4.2% of market cap · 18.4× smaller than top peer BioNTech ($780M)
56 active patent families
Where Evotec innovates
Molecular biologyDiseasePhysicsDisease injuryDisease patient
Tracks the peer median across all five Patsnap quality dimensions.
Quality vs same-sector peers
Evotec on the five Patsnap quality dimensions
Evotec in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Evotec concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Evotec and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Evotec on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.